Inés Pérez‐Camacho

Impact of ceftazidime/avibactam versus best available therapy on mortality from infections caused by carbapenemase-producing Enterobacterales (CAVICOR study)

Juan José Castón, Ángela Cano, Inés Pérez‐Camacho et al. · Journal of Antimicrobial Chemotherapy · 2022 · 66 citations

Pharmacy, Infectious Diseases, Pharmacotherapy +17

Catheter-related bloodstream infections: predictive factors for Gram-negative bacteria aetiology and 30 day mortality in a multicentre prospective cohort

Federica Calò, Pilar Retamar, Pedro María Martínez Pérez-Crespo et al. · Journal of Antimicrobial Chemotherapy · 2020 · 51 citations

Life Sciences, Infectious Diseases, Microbiology +13

Prevalence and Risk Factors for Abnormal Liver Stiffness in HIV-infected Patients without Viral Hepatitis Coinfection: Role of Didanosine

Nicolás Merchante, Inés Pérez‐Camacho, José Antonio López Mira et al. · Antiviral Therapy · 2010 · 47 citations · Full text

Medicine, Infectious Diseases, Internal Medicine +12

Incidence of Liver Damage of Uncertain Origin in HIV Patients Not Co-Infected with HCV/HBV

Antonio Rivero‐Juárez, Ángela Camacho, Nicolás Merchante et al. · PLoS ONE · 2013 · 39 citations · Full text

Medicine, Infectious Diseases, Internal Medicine +11

Evaluation of eosinophilia in immigrants in Southern Spain using tailored screening and treatment protocols: A prospective study

Joaquín Salas-Coronas, María Teresa Cabezas-Fernández, José Vázquez-Villegas et al. · Travel Medicine and Infectious Disease · 2015 · 34 citations

Public Health, Community Medicine, Epidemiology +9